Lung hydatidosis treatment: which are the associated morbidity and mortality risk factors ?
Z. Chaari (Sfax, Tunisia), A. Hentati (Sfax, Tunisia), A. Ben Ayed (Sfax, Tunisia), W. Abid (Sfax, Tunisia), I. Frikha (Sfax, Tunisia)
Source: International Congress 2022 – Pleural and other respiratory infections
Session: Pleural and other respiratory infections
Session type: Thematic Poster
Number: 1102
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Chaari (Sfax, Tunisia), A. Hentati (Sfax, Tunisia), A. Ben Ayed (Sfax, Tunisia), W. Abid (Sfax, Tunisia), I. Frikha (Sfax, Tunisia). Lung hydatidosis treatment: which are the associated morbidity and mortality risk factors ?. 1102
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|